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Radioscopy laboratory diagnostic of epizootic 
diseases in Belgium and European countries 
Introduction 
Belgium and other European neighbouring countries faced several emerging and re-emerging diseases as well as zoonotic diseases 
over the last decade. However, it has been noticed that during these episodes adequate laboratory diagnostic capabilities were  the 
clue to rapidly control and eradicate these diseases. An updated crisis scenario book, as it is implemented in the Belgian national 
laboratory (NRL), has showed all its usefulness during these situations. 
Belgium plays a key role in international animal trade making it very sensitive to disease introduction via different pathways e.g. trade 
of live animals or animal products from around the world or via wildlife (translocation). It is therefore crucial to react quickly to these 
diseases, to establish appropriate contingency plans and to develop reliable diagnostic tests. Moreover, only few publications regarding 
the increase of diagnostic capacities are available in the scientific literature.  
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Materials and methods 
Based on 29 selected diseases (Bianchini J., personal communication), a mapping of existing techniques was created. An overview of 
assays available and which would be used in different scenarios (risk importation, early detection, spread and freedom of disease) in 
national  and international laboratories was established. If gaps were detected, international laboratories were contacted in order to 
create future partnerships. These data were completed by the analysis of the World Animal Health Information System (WAHIS) 
online tools of the World Organization for Animal diseases (OIE) for the 40 major European countries (possibilities and assays used) 
encoded for 23 of the 29 diseases included in the OIE list. 
Results and perspectives 
Frequency of the different assays used in the Belgian laboratories (fig. 2a) and in Europe (fig. 2b)  













These surveys have showed that virus isolation and virus neutralization test are sensitive and specific and are therefore often 
considered as gold standard confirmation tests. However, they are slow, laborious and require biosafety laboratory facilities. For many 
diseases, enzyme-linked immunosorbent assays (ELISA) are often used and commercially available. Although its rapidity, often 
good sensitivity and specificity, ELISA needs to be standardized and fit for purpose which requires training and experience. Molecular 
methods such as the polymerase chain reaction (PCR or mostly real-time PCR) are very specific and sensitive which give qualitative 
and/or quantitative result in a few hours but need adequate material (e.g. good extraction protocol). In addition, PCR’s are very often 
sequence-dependent and thus sensitive to mutations and contaminations which can lead to false negative results. Sequencing offers 
promising solutions but is currently only used as confirmation for first suspicious samples and is still restrained for research purposes 
because of the price for the equipment, the samples preparation and the requirement for trained staff. 
On the other hand, this project suggests the importance of implementing, keeping up-to-dated online data at European level for          
(re-)emerging diseases, especially for Cache valley virus, Aino disease, Nipah disease, Porcine deltacoronavirus. 
 In conclusion, it was showed that Belgium is able to establish a diagnostic for 25 of the 29 of targeted diseases and underlined the 
importance of collaboration between laboratories permitting Belgium to have the diagnostic capacities to face all situations 
mentioned  in the scenarios. 
 
This work will help the Veterinary Authorities to take a faster, precise and well documented  
decision in case of an epidemic in Belgium. 
This study was funded by the Federal Public Service of Health, Food Chain Safety and Environment  
(contract RT 13/3 EPIDIACAP) 
 
Using LimeSurvey® web application and the WAHIS online tools, a large survey in Belgium and in Europe has been completed to 
implement a specific database and to determine laboratory capacities in Europe. Using four scenario analyses (risk of importation, 
early detection, spread and freedom of disease) diagnostic flow charts and questions, concerning kits characteristics (e.g. sensibility & 
specificity), as well as additional questions regarding laboratory capacities, the experience and the degree of accreditation were asked. 
All data were gathered online in decision trees using Cmap® software. Also bilateral partnerships (techniques and/or collaboration 







Laboratoire national + 2 laboratoires régionaux 
Laboratoire national 
Laboratoire régional 
2 laboratoires régionaux 
Laboratoire national + 1 laboratoire régional regional  




Number of diseases detected in routine in the national and regional Belgian laboratories 
 
Sum of possibilities of detection for the 23 selected diseases in the 40 European countries encoded in 
WAHIS 






Enzyme-Linked Immunosorbent Assays  
Real-Time Polymerase Chain Reaction  




 Example of  a generic decision tree 
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